このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Dementia Phenotypes in Primary Care, Hospital, and National Mortality Registries

2015年9月11日 更新者:Harry Hemingway、University College, London

Dementia Phenotypes in Primary Care, Hospital, and National Mortality Registries: a Cohort Study in Linked Electronic Health Records

Most patients with dementia in the UK use their local hospitals and general (family) practices throughout their illness. Linked electronic health records from primary care, hospital and death certificates records therefore provide useful information about the diagnosis and prognosis of patients who develop dementia.

In this study we will assess the validity of dementia diagnoses in linked primary care, hospital and death records, by examining the timing of important health transitions in patients with recorded dementia, and we will estimate the lifetime risk of recorded dementia in different age and sex groups

調査の概要

状態

わからない

条件

詳細な説明

Dementia is a clinical syndrome with insidious onset that is difficult to diagnose in its earliest stages. Presentation to healthcare depends not only upon the rates of disease progression, but also on social support, recognition by clinicians, and patients' and carers' fear of diagnosis. Maintaining complete follow up in cohorts of patient with dementia is difficult, because patients with dementia are frequently lost to follow up.

Most patients with dementia in the UK use their local hospitals and general (family) practices throughout their illness. Linked electronic health records from primary care, hospital and death certificates records should therefore provide useful information about the diagnosis and prognosis of patients who develop dementia with minimal loss to follow-up rates and improved completeness of diagnosis.

Demonstrating that patients with recorded dementia have an earlier onset of typical symptoms, functional impairment and death than patients in the general population would support the veracity of diagnosed dementia recorded in electronic health records and its use as an outcome or exposure in cohort studies and for evaluating policy. Previous studies have found that dementia is poorly recorded in routine clinical practice in comparison to face-to-face studies, although this varies by setting and region. However, ascertainment may be improved by examining linked, longitudinal resources. Comparing the lifetime risk of dementia calculated from linked electronic health records with lifetime risks from other sources will also be a useful information to support the use of linked electronic health records in dementia research.

Electronic health records contain information on important health transitions in patients with dementia: from the earliest stage of the illness (depression, anxiety, memory complaints); the development of cognitive impairment that manifest as loss of capacity or missed appointments; and significant functional impairment, with admission to nursing homes or hospital admission. In this study, we will assess the validity of dementia diagnoses in linked primary care, hospital and death records, by examining the timing of important health transitions in patients with recorded dementia, and estimate the lifetime risk of recorded dementia in different age and sex groups.

研究の種類

観察的

入学 (予想される)

51000

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

      • London、イギリス
        • London Farr Institute of Health Informatics

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年歳以上 (大人、高齢者)

健康ボランティアの受け入れ

はい

受講資格のある性別

全て

サンプリング方法

非確率サンプル

調査対象母集団

Patients registered in English general practices contributing with data to the CALIBER research platform from 1997 onward.

説明

Inclusion Criteria:

  • Patients aged 18 years and over
  • Registered with a participating general practice during the study period
  • Minimum one year of records prior to study entry meeting CPRD data quality criteria
  • Followed on or after 1 January 1997

Exclusion Criteria:

  • Patients without recorded gender
  • Less than 1 year of follow-up between study entry and date of administrative censoring

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

コホートと介入

グループ/コホート
介入・治療
Dementia
Patients with a recorded diagnosis of dementia in primary or secondary care
This study is based on the retrospective analysis of linked electronic health records.
Non-dementia
Patients without a recorded diagnosis of dementia in primary or secondary care
This study is based on the retrospective analysis of linked electronic health records.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Proportion of patients with dementia diagnosis (any type) in primary care that also are recorded in secondary care
時間枠:10 years
10 years
Factors associated with dementia diagnosis (any type) recording in mortality data only
時間枠:10 years
These will be estimated from multivariable logistic regression models
10 years
Symptoms associated with subsequent diagnosis of dementia
時間枠:10 years
These will be estimated from multivariable logistic regression models
10 years
Lifetime risk of dementia (any type)
時間枠:10 years
10 years
Lifetime risk of mortality associated with dementia (any time)
時間枠:10 years
10 years
Factors associated with dementia diagnosis (any type) recording in secondary care only
時間枠:10 years
These will be estimated from multivariable logistic regression models
10 years
Factors associated with dementia diagnosis (any type) recording in primary care only
時間枠:10 years
These will be estimated from multivariable logistic regression models
10 years
Proportion of patients with dementia diagnosis (any type) in primary care that also are recorded in mortality data
時間枠:10 years
10 years
Proportion of patients with dementia diagnosis (any type) in secondary care that also are recorded in mortality data
時間枠:10 years
10 years

二次結果の測定

結果測定
時間枠
Proportion of patients with Alzheimer's disease in primary care that are also diagnosed in secondary care
時間枠:10 years
10 years
Proportion of patients with vascular dementia in primary care that are also diagnosed in secondary care
時間枠:10 years
10 years
Lifetime risk of Alzheimer's disease
時間枠:10 years
10 years
Lifetime risk of vascular dementia
時間枠:10 years
10 years
Lifetime risk of mortality associated with Alzheimer's disease
時間枠:10 years
10 years
Proportion of patients with Alzheimer's disease in primary care that are also diagnosed in mortality data
時間枠:10 years
10 years
Proportion of patients with Alzheimer's disease in secondary care that are also recorded in mortality data
時間枠:10 years
10 years
Proportion of patients with vascular dementia in primary care that are also recorded in secondary care
時間枠:10 years
10 years
Proportion of patients with vascular dementia in secondary care that are also recorded in mortality data
時間枠:10 years
10 years

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始

2015年9月1日

一次修了 (予想される)

2015年10月1日

研究の完了 (予想される)

2015年12月1日

試験登録日

最初に提出

2015年9月3日

QC基準を満たした最初の提出物

2015年9月11日

最初の投稿 (見積もり)

2015年9月15日

学習記録の更新

投稿された最後の更新 (見積もり)

2015年9月15日

QC基準を満たした最後の更新が送信されました

2015年9月11日

最終確認日

2015年9月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • 15_138

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

3
購読する